Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Oct;76(10):1326-1341.
doi: 10.1111/anae.15440. Epub 2021 Mar 2.

A pilot multicentre randomised controlled trial of lidocaine infusion in women undergoing breast cancer surgery

A J Toner  1 , M A Bailey  2 , S A Schug  1 , T B Corcoran  1
Affiliations
Free article
Randomized Controlled Trial

A pilot multicentre randomised controlled trial of lidocaine infusion in women undergoing breast cancer surgery

A J Toner et al. Anaesthesia. 2021 Oct.
Free article

Abstract

Chronic postoperative pain is common after breast cancer surgery. Peri-operative lidocaine infusion may prevent the development of chronic postoperative pain, but a large-scale trial is required to test this hypothesis. It is unclear whether a pragmatic, multicentre trial design that is consistent with expert guidance, addresses the limitations of previous studies, and overcomes existing translational barriers is safe, effective and feasible. We conducted a double-blind, randomised controlled pilot study in 150 patients undergoing breast cancer surgery across three hospitals in Western Australia. Patients received lidocaine, or equivalent volumes of saline, as an intravenous bolus (1.5 mg.kg-1 ) and infusion (2 mg.kg-1 .h-1 ) intra-operatively, and a subcutaneous infusion (1.33 mg.kg-1 .h-1 ) postoperatively for up to 12 h on a standard surgical ward, with novel safety monitoring tools in place. The co-primary outcomes were: in-hospital safety events; serum levels of lidocaine during intravenous and subcutaneous infusion; and annualised enrolment rates per site with long-term data capture. In-hospital safety events were rare, and similar in the placebo and lidocaine arms (3% vs. 1%). Median (IQR [range]) serum lidocaine levels during intravenous (2.16 (1.74-2.83 [1.12-6.06]) µg.ml-1 , n = 41) and subcutaneous (1.52 (1.28-1.83 [0.64-2.85]) µg.ml-1 , n = 48) infusion were comparable with previous trials reporting improved pain outcomes. Annualised enrolment approximated 50 patients per site per year, with high levels of protocol adherence and ≥ 99% capture of outcomes at 3 and 6 months. The adjusted odds ratio (95%CI) for postoperative pain at 6 months in the lidocaine arm was 0.790 (0.370-1.684). We conclude that this trial, as designed, is safe, effective and feasible in patients undergoing breast cancer surgery, and a larger-scale trial is planned.

Keywords: breast cancer surgery; chronic postoperative pain; lidocaine infusion.

PubMed Disclaimer

References

    1. Chan MT, Peyton PJ, Myles PS, et al. Chronic postsurgical pain in the Evaluation of Nitrous Oxide in the Gas Mixture for Anaesthesia (ENIGMA)-II trial. British Journal of Anaesthesia 2016; 117: 801-11.
    1. Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet 2019; 393: 1537-46.
    1. Schug SA. Pain after surgery-acute becomes chronic: might there be a silver ROCKet? Anaesthesia and Intensive Care 2017; 45: 439-40.
    1. Deloitte. The Cost of Pain in Australia. 2019. www2.deloitte.com/au/en/pages/economics/articles/cost-pain-australia.html (accessed 26/01/2021).
    1. Treede RD, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain 2015; 156: 1003-7.

Publication types

LinkOut - more resources